Kopran Ltd share price logo

Kopran Ltd

NSE: KOPRAN

BSE: 524280

Small Cap

Pharma Sector

₹155.00

-1.32

(-0.84%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kopran Stock Performance

as on May 18, 2026 at 3:02 pm IST

  • Day's Low

    Day's High

    ₹153.81
    ₹155.93
    downward going graph

    0.77%

    Downside

    0.60%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹107.00
    ₹212.58
    downward going graph

    30.97%

    Downside

    37.15%

    Upside

    downward going graph

Kopran share price movements today

Previous Close
₹156.32
Open
₹155.00
Volume
15.74K
Upper Circuit
₹187.58
Lower Circuit
₹125.06
Day's Low - High
₹153.81 - ₹155.93
52 Week Low - High
₹107.00 - ₹212.58

Kopran Historical Returns

1 Month Return
+ 0.64 %
3 Month Return
+ 17.21 %
1 Year Return
-15.97 %
3 Year Return
+ 6.85 %
5 Year Return
-15.59 %

Kopran Fundamentals

as on May 18, 2026 at 9:32 am IST

Market Cap

₹754.80 Cr

Return on Equity (ROE)

6.33

PE Ratio (TTM)

45.71

Return on capital employed (ROCE)

8.54

Industry PE ratio

45.6

Beta (LTM)

1.41

P/B Ratio

1.96

Dividend Yield

1.71

PEG Ratio

-7.11

Quarterly Earnings Growth YOY

-10.19

EPS (TTM)

7.98

Sector

Pharmaceuticals

Book Value

107.35

Kopran Stock Valuation

as on May 18, 2026 at 9:32 am IST

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Industry (45.60x)

May 15, 2026

Today (45.71x)

May 15, 2026

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 45.71x

Kopran Technical Analysis

Track how Kopran technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish9
Bullish1
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
-0.29
Bullish
CCI (20)
-19.95
Neutral
RSI (14)
46.24
Neutral
Momentum (10)
-0.59
Neutral
ADI (14)
20.9
Neutral
Ultimate Oscillator (7,14,28)
47.48
Neutral

Moving Averages

Name

Value

Action

SMA (20)
154.76
Bearish
EMA (20)
154.67
Bearish
VWMA (20)
154.57
Bearish
SMA (50)
155.35
Bearish
EMA (50)
155.24
Bearish
SMA (200)
157.07
Bearish
EMA (200)
156.71
Bearish
KAMA (200)
155.35
Bearish
DEMA (200)
155.63
Bearish

Kopran Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kopran Ltd image
Kopran Ltd
NA754.80-3.12%0.6238629
Rajnish Wellness Ltd image
Rajnish Wellness Ltd
NA45.6932.94%0.00148
Themis Medicare Ltd image
Themis Medicare Ltd
NA899.1721.22%0.5929405
Hikal Ltd image
Hikal Ltd
BUY2,484.02-8.27%0.70901,859
Venus Remedies Ltd image
Venus Remedies Ltd
NA1,218.8039.08%0.5045647
See all

Kopran Stock’s Investor Sentiment and Interest

Search interest for Kopran Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

Kopran Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
117
152.59
158.92
186.08
139.44
151.56
166.24
172.36
135.22
117.91
194.28
Other Income
2.39
0.13
2.43
9.67
2.63
1
0.17
3.26
2.56
0.03
0.07
Total Income
119.39
152.72
161.35
195.75
142.06
152.56
166.41
175.62
137.77
117.93
194.35
Expenses
110.69
129.76
135.34
164.39
121.27
136.82
146.4
155.28
121.09
123.19
176.52
Operating Profit
6.31
22.83
23.58
21.69
18.17
14.74
19.84
17.08
14.13
-5.28
17.76
Operating Profit Margin %
5.39%
14.96%
14.84%
11.66%
13.03%
9.73%
11.93%
9.91%
10.45%
-4.48%
9.14%
Profit Before Interest, Tax and Depreciation
8.7
22.96
26.01
31.36
20.79
15.73
20.01
20.35
16.69
-5.25
17.83
Interest
1.83
1.94
2.24
2.59
2.18
2.23
2.16
2.77
2.54
2.09
2.67
Depreciation
3.26
2.77
3.27
3.59
3.87
3.85
4
3.87
4.26
4.28
4.42
Profit Before Tax
3.61
18.25
20.5
25.18
14.74
9.65
13.85
13.71
9.89
-11.62
10.74
Tax Paid
0.83
4.48
4.72
6.55
3.64
2.26
3.46
4.03
2.44
-1.7
1.4
Profit After Tax
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
9.34
Total Net profit including share of profit / Loss from associate company
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
9.34
EPS
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Actual EPS
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Adjusted EPS
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Diluted EPS
0.58
2.85
3.28
3.85
2.3
1.53
2.15
2.01
1.54
-2.06
1.93

Kopran Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
314.71
357.9
359.5
491.81
477.52
550.99
614.59
629.6
Other Income
9.6
3.06
0.63
17.99
10.6
3.07
14.61
3.98
Total Income
324.3
360.96
360.13
509.8
488.13
554.05
629.2
633.59
Expenses
284.31
311.57
313.36
410.03
390.13
499.19
540.18
556.7
Operating Profit
30.4
46.33
46.14
81.78
87.39
51.8
74.41
72.9
Operating Profit Margin %
9.66%
12.94%
12.83%
16.63%
18.3%
9.4%
12.11%
11.58%
Profit Before Interest, Tax and Depreciation
39.99
49.39
46.77
99.77
98
54.86
89.02
76.88
Interest
8.6
8.99
8.91
6.24
5.12
6.08
8.59
9.34
Depreciation
8.51
8.74
9.58
10.19
11.1
12.71
12.89
15.59
Profit Before Tax
22.88
31.66
28.28
83.34
81.78
36.07
67.54
51.95
Tax Paid
2.4
7.64
7.27
21.73
20.75
8.83
16.59
13.39
Profit After Tax
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
Total Net profit including share of profit / Loss from associate company
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
EPS
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Actual EPS
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Adjusted EPS
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Diluted EPS
4.74
5.55
4.86
14.24
13.77
5.65
10.55
7.99

Kopran Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
28.63
15.87
25.77
25.41
31
59.95
-33.48
34.02
43.26
41.94
Cash Flow from Investing Activities
-9.07
-17.97
-10.98
-24.86
-12.51
-28.96
-84.13
-12.58
-43.55
-56.42
Cash Flow from Financing Activities
-19.34
1.97
-15.02
-0.59
-18.06
-34.58
122.82
-19.84
0.99
25.88
Net Cash Flow
0.22
-0.12
-0.22
-0.03
0.42
0.1
4.93
1.53
0.69
11.38

Kopran Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
44.49%
44.49%
44.49%
44.49%
44.49%
44.49%
44.46%
44.42%
44.42%
44.42%
44.42%
44.42%
DII
0.14%
0.35%
0.14%
1.2%
0.14%
0.22%
0%
0%
0%
0%
0%
0%
FII
0%
0%
0.48%
0.84%
0.68%
1.32%
0.86%
1.12%
0.76%
0.6%
0.36%
0.57%
Public
55.03%
54.77%
54.89%
53.47%
54.7%
53.97%
54.68%
54.45%
54.82%
54.98%
55.22%
55%
Total Outstanding Shares
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,49,405
4,82,85,605
4,82,85,605
4,82,85,605
4,82,85,605
4,82,85,605
Total Shareholders
44,038
53,791
51,636
50,850
51,492
57,154
60,560
58,652
60,194
62,222
60,886
58,639

Mutual Funds that own Kopran Stock

Check out the Mutual Funds with significant holdings in Kopran.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.03%
330

Kopran Corporate Actions

View detailed summary of the earnings and dividend history of Kopran.

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -10.19% since last year same period to ₹9.34Cr in the Q3 2025-2026. On a quarterly growth basis, Kopran Ltd has generated 194.15% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Kopran Ltd Dividends May,2025

    In the quarter ending March 2025, Kopran Ltd has declared dividend of ₹3.00 per share on 15 May 2025 - translating a dividend yield of 3.84%.

    Read More about Dividends

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Healthcare

₹46,926.00

-0.57 (▲267.13%)

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 117.93 Cr → 194.35 Cr (in ₹), with an average increase of 39.3% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.36% to 0.57% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -9.92 Cr → 9.34 Cr (in ₹), with an average increase of 206.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, KOPRAN stock has moved up by 17.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.42% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 33.4% return, outperforming this stock by 49.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 166.0% return, outperforming this stock by 159.1%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 55.22% to 55.00% in Mar 2026 quarter

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹194.28Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.34Cr as on December 2025 (Q3 FY26)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
IndustryPharmaceuticals
CEOSusheel Somani
E-voting on sharesClick here to vote

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹155 as on . Kopran share today touched a day high of ₹155.93 and a low of ₹153.81.

What is the 52 week high and 52 week low range for Kopran share?

Kopran touched a 52 week high of ₹212.58 and a 52 week low of ₹107. Kopran share price today i.e. is trending at ₹155, which is -27.09% down from its 52 week high and 44.86% up from its 52 week low.

What is Kopran's market capitalisation today?

Kopran market capitalisation is ₹754.80 Cr as on .

How to buy Kopran shares?

To buy Kopran shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KOPRAN or Kopran Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kopran shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kopran trading volume today?

Kopran trading volume is 15.74K as on . This means that 15.74K shares of Kopran were bought and sold on the stock market during today's trading session.